(Q48615461)

English

Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?

scientific article published in July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

substantia nigra

1 reference

based on heuristic

inferred from title

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Indrani Datta

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

Ramesh Bhonde

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

publication date

1 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

Cell Biology International

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

36

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

617-624

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

Brain Peroxidase and Catalase in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Head trauma preceding PD: a case-control study.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Genetic susceptibility in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

The sensitivity of human mesenchymal stem cells to ionizing radiation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Ischemic rat brain extracts induce human marrow stromal cell growth factor production

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Glutathione peroxidase, glial cells and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Early detection of Parkinson's disease. Implications for treatment

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Mefloquine induces dose-related neurological effects in a rat model

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Memory impairment induced by low doses of reserpine in rats: possible relationship with emotional processing deficits in Parkinson disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Organization of neurology services in India: unmet needs and the way forward

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Effect of bone marrow-derived mesenchymal stem cells on endotoxin-induced oxidation of plasma cysteine and glutathione in mice

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Metals, oxidative stress and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Inflammatory bowel disease: Moving toward a stem cell-based therapy

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Immunomodulatory effects of fetal and adult mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Migration and differentiation of human mesenchymal stem cells in the normal rat brain

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Projected neurodegenerative disease mortality in the United States, 1990-2040.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Extracellular superoxide dismutase

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Absolute requirement of GDNF for adult catecholaminergic neuron survival

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Verapamil-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Treatment of Parkinson's disease with trophic factors

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Parkinson's disease mortality and pesticide exposure in California 1984-1994.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Manganese accumulation in the CNS and associated pathologies.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Artistic profession: a potential risk factor for dopamine dysregulation syndrome in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Human mesenchymal stem cells efficiently manage oxidative stress

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Oxidative neurotoxicity in rat cerebral cortex neurons: Synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen‐activated protein kinase and caspase‐3

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Antipsychotic-induced movement disorders - forgotten but not gone

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Trophic factors attenuate nitric oxide mediated neuronal and axonal injury in vitro: roles and interactions of mitogen-activated protein kinase signalling pathways.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

The possible role of iron in the etiopathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110602

21 January 2018

Identifiers

10.1042/CBI20110602

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22417707

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48615461&oldid=1448541849"